90results about How to "Does not affect the efficacy" patented technology

The invention discloses a liver-clearing and vision-improving boxthorn leaf traditional Chinese medicine tea. The traditional Chinese medicine tea comprises the following raw material medicines in parts by weight: 10-30 parts of boxthorn leaf, 10-20 parts of polygonum cuspidatum, 10-20 parts of Chinese angelica, 10-20 parts of jasmine, 10-20 parts of radix ophiopogonis, 10-20 parts of codonopsis pilosula, 10-20 parts of schisandra chinensis, 10-20 parts of radix polygonati officinalis, 10-20 parts of cuscuta chinensis, 10-20 parts of wolfberry fruit, 10-20 parts of prepared rhizome of rehmannia, 10-20 parts of prepared fleece flower root, 10-20 parts of eucommia ulmoides, 10-20 parts of glossy privet fruit, 10-20 parts of rhizoma polygonati, 10-20 parts of white paeony root and 10-20 parts of semen cassiae. The boxthorn leaf is cool in nature, bitter in taste and non-toxic and has the effects of tonifying deficiency, replenishing vital essence, clearing away heat, quenching thirst, dispelling the wind, improving the vision, treating hot eyes and pain, treating heat toxin sore and the like, and by adopting a modern process, the boxthorn leaf tea making is systematically researched, the prepared boxthorn leaf tea is good in mouthfeel and high in aroma, does not have green odor and can be accepted by consumers. For the boxthorn leaf tea, traditional Chinese medicines with the effects of nourishing liver and kidney and mild in nature and flavor are added, and the tea has obvious effects on dry and unsmooth eyes and unclear and fuzzy object observation caused by liver-kidney deficiency and excessive eyes.

The invention relates to a rotary pinpoint medicine preparing intelligent kit and a medicine preparing method thereof. The kit comprises a base, a first driving motor, a medicine preparing box, a sliding channel, a buzzer, medicine placing bottles, a medicine bottle rack, a positioning bracket, a positioning switch, a C-shaped protecting groove, a return spring, a rocker, a second driving motor, acontroller, a battery, an operation panel and a medicine box housing, wherein the first driving motor is fixed to the center of the base and is connected with the medicine bottle rack, a plurality ofmedicine placing bottles are arrayed axially on the medicine bottle rack, a medicine receiving plate is arranged at the bottom of each medicine placing bottle, the C-shaped protecting groove is located between a tablet passage and the corresponding medicine receiving plate, and is fixed to the tablet passage or the corresponding medicine receiving plate through a pin shaft to surround tablets, and the second driving motor is fixed on the base to drive the rocker to rotate; and the rocker can prod the C-shaped protecting groove to rotate around the pin shaft while rotating, and the tablets onthe medicine receiving plate are pushed out. The kit is simple in structure and convenient to use, can automatically complete medicine preparation according to set time and remind people of taking medicines, and the difficult problem that old people need to take medicines, is solved.

The invention relates to a composition capable of degrading pesticide residue and an application of the composition capable of degrading pesticide residue, and belongs to the technical field of crop cultivation. The composition capable of degrading pesticide residue provided by the invention comprises the following active components in parts by weight: 1 part of algal polysaccharides, 0.05-20 parts of rare earth, and 0.05-20 parts of gibberellic acid. According to the composition capable of degrading pesticide residue, under the premise that the pesticide effect is not influenced, the pesticide residue quantity in the crop products before harvest can be stably and greatly reduced, the pesticide residues on the surface of agricultural products can be removed, the pesticide residue quantity of agricultural products can be reduced, and the food security of the crop product in the market is guaranteed; the composition capable of degrading pesticide residue is prepared by using the conventional raw materials, and the preparation method is simple and low in cost.

The invention belongs to the field of medical sterilization and particularly relates to a benzalkonium chloride solution and a preparation method thereof. The benzalkonium chloride solution comprises, by mass, 0.13%-0.21% of benzalkonium chloride, 0.05%-0.2% of triclosan, 1%-2% of nonionic surfactant, 0.5%-2.0% of EDTA-2Na, 5%-10% of aloe extract, 1%-5% of vitamin E, 1.0%-5.0% of penetrant, 1.5%-3.0% of synergist and the balance water for injection. The benzalkonium chloride solution has the advantages of no irritation, resistance to organic matter interference, high disinfection performance and capabilities of promoting wound healing and scar fading and is applicable to cleaning and disinfection of the skin, wound mucous membranes and operative sites.

The invention discloses a production technology of compound sodium gualenate gargle. The production technology comprises the steps of preparing a solution I: heating purified water, then adding non-crystalline sorbitol, sodium benzoate and cetylpyridinium chloride into the heated purified water, and stirring for 20min; preparing a solution II: dissolving sodium gualenate by using ethanol to obtain the solution II; preparing a solution III: heating RH40 hydrogenated castor oil and propylene glycol until being molten, adding spearmint essence, and evenly stirring to obtain the solution III; adding the solution II and the solution III into the solution I, stirring for 10min to obtain a semi-finished product, taking samples for laboratory test to obtain a cetylpyridinium chloride semi-finished product, and canning the semi-finished product when the semi-finished product is qualified; when the cetylpyridinium chloride is insufficient, adding the cetylpyridinium chloride, taking samples for detection until the semi-finished product is qualified, and starting to fill; after the finished product is tested to be qualified, enabling the finished product to be put in storage, and discarding the unqualified products.

The invention discloses a traditional Chinese medicinal material packaging machine. The traditional Chinese medicinal material packaging machine comprises a machine body. Supporting feet are arranged at the bottom of the machine body. A base is arranged on the tops of the supporting feet. A control panel is arranged on the outer side of the base. A conveying belt is arranged inside the base. A weight sensor is arranged in the conveying belt. An output channel is arranged on the right side of the conveying belt. A packaging box is arranged on the left side of the top of the base. The top of the machine body is connected with a transverse rod through supporting columns. A medicine feeding hopper is arranged on the top of the transverse rod. The bottom of the medicine feeding hopper is connected with a metering cylinder. A medicine outlet pipe is arranged at the bottom of the metering cylinder. An electromagnetic valve is arranged on the outer side of the medicine outlet pipe. The right side of the bottom of the transverse rod is connected with a telescopic rod. A sealing plate is arranged at the bottom of the telescopic rod. According to the traditional Chinese medicinal material packaging machine, the packaging time of medicinal materials is shortened, the medical efficiency is improved, the treatment of patients is not delayed under the situation that many patients see a doctor, and the illness state of the patients can be recovered as fast as possible.

The present invention relates to a medicine plaster for external application, in particular, it is a transdermal plaster containing caowujiasu. Said plaster has medicine storage unit, back-lining layer and protecting layer. Said medicine storage unit is formed from caowujiasu and storage matrix, every plaster contains 0.1mg-100 mg of caowujiasu, and the rest is storage matrix. The medicine-releasing area of said plaster is 1 sq.cm-100 sq.cm, and the transdermal speed rate is 0.05 microgram/h.sq.cm, and its continuous medicine-releasing time is 1-12 days. Its theapeutic effect is reliable, quality is stable and convenient in application.

The invention discloses an automatic traditional Chinese medicine material processing device comprising a shell and water tanks arranged on the two sides of the shell. A drying bin used for drying washed medicine materials is arranged at the bottom end in the shell, and a washing bin used for washing materials is arranged at the upper end in the shell. The part, at the bottom of the drying bin, ofthe shell is provided with a discharge outlet, and a high-temperature drying pipe is arranged at the top. The top of the drying bin communicates with the washing bin through a material guide pipe. The bottom of the washing bin is provided with two water outlets. The top of the shell is provided with a feed inlet. A rotary motor is arranged at the top, on one side of the feed inlet, of the shell.A rotary shaft is arranged at the output end of the rotary motor. A washing brush is arranged on the surface of the rotary shaft. The automatic traditional Chinese medicine material processing deviceis provided with a series of structures, thereby having the advantages that operation is convenient, processing efficiency is high, manpower is saved, and efficiency is improved.

The invention discloses a thifluzamide oil suspension and a preparation method thereof. The thifluzamide oil suspension takes thifluzamide, a solvent, a thickener, a dispersant and a PH regulator as raw materials. The preparation method of the thifluzamide oil suspension comprises the following steps: firstly, carrying out pretreatment to thifluzamide and the thickener, then stirring all the raw materials by mixing together, throwing into a sand mill to be ground to a particle size below 5 mu m, adding the PH regulator and filtering at last so as to obtain the thifluzamide oil suspension. The quality analysis results of the product show that the decomposition rate of active ingredients is less than 3%, the suspension rate is more than 90%, phenomena of precipitation, agglomeration and stratification do not exist in low-temperature storage, the stability of the thifluzamide oil suspension is qualified, and phenomena of precipitation, agglomeration and stratification are not generated in heat storage at the temperature of 54+/-2 DEG C for 14 days. The thifluzamide oil suspension has simple formula and production process, convenience for use and low production cost and adopts domestic additives completely; an organic solvent is not used to greatly lower the environmental pressure; and the control effect for rice sheath blight, false smut, wheat sheath blight and loose smut of cereal crops is better.

The invention relates to a traditional Chinese medicinal composition, especially to a traditional Chinese medicinal composition for treating dysmenorrhoea and a preparation thereof. The formula of the composition comprises the following traditional Chinese medicinal raw medicines: 3-6 kg of tarragon, 6-12 kg of Cyperus Rotundus L with vinegar, 3-6 kg of evodia, 3-6 kg of Ligusticum wallichii, 0.5-1.0 kg of cassia twig, 100-400 g of borneol and 1.5-4.5 g of capsicine.

The invention discloses a pharmaceutical preparation containing rifaximin gel and rifaximin oral emulsion and a preparation method thereof, wherein the gel comprises rifaximin and a gel matrix, the mass ratio of the rifaximin to the gel matrix is (2-80):(5-64), and the gel matrix comprises 2-30 parts by weight of a water-soluble gel matrix and 0.5-2 parts by weight of a modifier; and the rifaximin oral emulsion comprises 1-40 parts by weight of rifaximin, 50-350 parts by weight of an oil phase, 1-300 parts by weight of an emulsifier, and 0-150 parts by weight of a co-emulsifier. In the preparation, on the premise of guaranteeing that the dose of a main drug is appropriate, through the selection of auxiliary materials and preparation methods, rifaximin is prepared into gel or oral emulsion, thereby facilitating the oral administration and absorption of drugs, and achieving relatively high bioavailability. Meanwhile, a newer and better dosage form choice is provided for clinic.

The invention belongs to the technical field of medicines, particularly relates to the field of pharmacy, and more particularly relates to a tomoxetine hydrochloride oral liquid and a preparation method thereof. The tomoxetine hydrochloride oral liquid is mainly prepared from tomoxetine hydrochloride, a preservative, a pH regulator, a sweetening agent and a taste improver, wherein the taste improver is prepared from a thickening agent, mint essence and sweet orange essence. The taste improver prepared from the thickening agent, the mint essence and the sweet orange essence can significantly improve the taste of the tomoxetine hydrochloride oral liquid in the taking process, and significantly reduces the bitter taste during taking and the bitter taste of the oral cavity after taking. Meanwhile, a test verifies that the drug effect and the drug stability of an active drug are not affected by adding of the taste improver, and the quality of the tomoxetine hydrochloride oral liquid can beconsistent with that of an original drug.

The invention belongs to the technical field of biological pesticides, and in particular provides a solid-state fermentation production process of a Bacillus thuringiensis biological pesticide by utilizing food wastes to co-culture Bacillus thuringiensis and Bacillus subtilis. The production process comprises the following specific steps of: weighing a certain amount of dry food wastes, inoculating with a 10-30wt% mixed strain of Bt (Bacillus thuringiensis) and Bs (Bacillus subtilis), and fermenting while controlling the initial water content of the culture medium at 45 -60%, pH value at 6.5-8.5 and thickness at 1-6 cm for 40-50 hours to obtain the Bt biological pesticide raw powder. Compared with the Bt biological pesticide product prepared by Bt fermentation, the Bt biological pesticide product prepared by co-culturing Bs and Bt with the food wastes has higher titer, and can be directly used for agricultural production. The production process improves the utilization efficiency of the food wastes and the product titer, and realizes the resource treatment of the food wastes and the popularization of the pollution-free Bt biological pesticides.

The invention discloses a formula and preparation method of a health-care beverage.The health-care beverage is prepared from, by weight, 10-50 parts of flos chrysanthemi, 10-20 parts of feather cockscomb seeds, 10-20 parts of radix ophiopogonis, 10-20 parts of semen ziziphi spinosae, 10-20 parts of flos buddlejae, 10-20 parts of semen cassia, 10-20 parts of poria cocos, 10-20 parts of white hyacinth beans, 10-20 parts of radix geutianae, 10-20 parts of pericarpium citri reticulatae, 10-20 parts of liquorice roots, 10-20 parts of radix trichosanthis, 10-20 parts of fructus gardenia, 10-20 parts of fructus citrus sarcodactylis, 10-20 parts of cortex lycii radicis, 10-20 parts of herba leonuri, 10-20 parts of flos eriocauli, 10-20 parts of roselle calyx, 10-20 parts of common selfheal fruit-spike and 10-20 parts of flos albiziae.The health care beverage aims at the liver harming behaviors that urban office workers generally use computers for handling office business, watch the computers for a long time, excessively smoke cigarettes and drink wine, intemperately spend the nightlife, stay up late and excessively use the eyes to enable the eyes to be not relieved, has the effects of nourishing the liver and the kidney, benefiting yin, nourishing blood, tonifying deficiency, benefiting essential qi, dispelling wind and improving the eyesight and is high in pertinence.

The invention relates to a preparation method of an enteric preparation for treating cervical spondylosis. The method comprises the following steps: by using frankincense and myrrh as raw materials, performing extraction to obtain volatile oil, performing extraction on medicine residues, collecting the filtrate and a steam water decoction, performing concentration, performing dispersion treatmentto prepare a nanoemulsion, and finally performing beta-cyclodextrin inclusion on the nanoemulsion and the volatile oil to obtain a frankincense and myrrh nanoemulsion inclusion compound; and by usingrhizoma cyperi, rhizoma curcumae longae, rhizoma ligustici chuanxiong, radix clematidis, danshen root, radix cyathulae, radix angelicae sinensis, and honey-fried radix astragali as raw materials, adding water, performing heating reflux extraction, adding safflower during extraction, collecting the filtrate, performing concentration, and performing filtration to remove macromolecular impurities toobtain the enteric preparation. The enteric preparation overcomes the defect that a preparation prepared from medicines such as frankincense and myrrh for promoting blood circulation and removing blood stasis has irritation to the stomach, and many cervical spondylosis patients with stomach diseases cannot take the preparation for a long time, and the preparation enteric capsules and enteric-coated tablets absorbed through the intestine can effectively reduce gastric irritation, reduce the taken amount, and achieve the effect of improving or treating the cervical spondylosis.

The invention relates to the field of medicinal accessories, and specifically provides a drug carrier, a drug preparation and a preparation method. The drug carrier provided by the invention is prepared from two polypeptides or one of the pharmaceutically acceptable derivatives of the two polypeptides or combination of at least two of the pharmaceutically acceptable derivatives. The drug carrier can from a stable drug complex with a polar drug. On the premise of not influencing the drug effect, the drug carrier greatly reduces the drug degradation speed, thus prolongs the in-vivo half-life period of the drug in a human body, and realizes a slow release function of the drug. Meanwhile, the drug carrier also can improve the drug solubility and is favorable for enhancing the absorption and effect of the drug, thereby lowering the medical cost. The drug preparation provided by the invention comprises the polar drug and the drug carrier, and has the advantages of high safety, long in-vivo half-life period and high solubility. The preparation method of the drug preparation provided by the invention is simple and easy to operate, imposes no special requirements on the equipment, and doesnot increase the production cost.

The invention provides a freeze proof, dissolution increasing, oxidation resisting protector and its preparing process. It is characterized in that it is prepared by the following raw materials in weight portion as: 10%-80% carbowax200 to20000 portions, 0.1%-10% tween 20 to 80 portions, sodium bisulfite or sodium sulfite 0.5 to 5 portions, sodium chloride 5 to 100 portions.The protector can increase the clarity and stability of the biochemical peptide and Chinese herbal injection, thus prevents the problems of cloudiness after low temperature refrigeration in the storage and transportation process.

The invention provides phosphorylated radix cyathulae polysaccharide, enema thereof and a preparation method thereof. A preparation method of the enema of the phosphorylated radix cyathulae polysaccharide comprises the following steps: 1, extracting radix cyathulae polysaccharide; 2, preparing phosphorylated radix cyathulae polysaccharide; 3, preparing the enema of the phosphorylated radix cyathulae polysaccharide. The preparation method of the phosphorylated radix cyathulae polysaccharide comprises the following steps: adding the radix cyathulae polysaccharide into distilled water and nitric acid; heating and adding sodium phosphate and barium chloride; regulating a pH value; filtering; adding a filtrate into anhydrous sodium sulfate for configuration by oscillation to obtain a centrifugate; redissolving the centrifugate and dialyzing in a dialysis bag to obtain the phosphorylated radix cyathulae polysaccharide. The enema of the phosphorylated radix cyathulae polysaccharide is prepared from the phosphorylated radix cyathulae polysaccharide with mass concentration of 2 to 6 percent, sodium chloride with mass concentration of 0.7 to 2.1 percent, and alkalinity-acidity buffer liquid with mass concentration of 0.1 to 0.3 percent. The enema of the phosphorylated radix cyathulae polysaccharide prepared by the invention can directly kill canine parvovirus, and has a good treatment effect on puppies infected with the canine parvovirus; moreover, the survival rate of dogs infected with the canine parvovirus can be effectively improved.

The invention discloses a portable type isothermal transfusion device. The portable type isothermal transfusion device comprises a heat source arranged under a transfusion tube and a control box arranged above the heat source, wherein the top end face of the control box is a hand resting tabletop; a U-shaped groove for embedding the transfusion tube is formed in the bottom end face of the control box; an airbag for adjusting the distance between the heat source and the transfusion tube is arranged between the control box and the heat source; an air inflation pump and an air leaking valve are arranged at an air inlet of the airbag; the control box is internally provided with a control module for controlling the air inflation pump and the air leaking valve to be switched on and off. The portable type isothermal transfusion device is arranged nearby a needle inserting position and is used for heating liquid in the transfusion tube, so that the comfort of a patient in a transfusion process is greatly improved on the basis of not influencing drug effects.

The invention discloses a compound spiramycin nanoemulsion oral liquid. The particle size of the oral liquid is 1-100nm, and the compound spiramycin nanoemulsion oral liquid comprises the following raw materials in percentage by weight: 15%-35% of surfactant, 3.95%-17.5% of cosurfactant, 0.2%-10% of oil phase, 0.2%-10% of spiramycin, 0.05%-2.5% of trimethoprim and the balance of deionized water, and the sum of the percentages by weight of all the raw materials is 100%. The content of the spiramycin in the nanoemulsion oral liquid can be up to 0.20%-10.00%, the appearance of the compound spiramycin nanoemulsion oral liquid is of colorless or light yellow transparent liquid, the bioavailability of the spiramycin can be significantly improved, and a strong in-vivo antibacterial effect and anantibacterial after effect can be further played. Simultaneously, the stability of a spiramycin medicament is improved, the shortcoming of bitter taste during oral administration of the spiramycin issolved, and the compound spiramycin nanoemulsion oral liquid further has the advantages of high safety, simple preparation and low energy consumption.